Literature DB >> 14514601

Prospective study of the association between the proline to alanine codon 12 polymorphism in the PPARgamma gene and type 2 diabetes.

Asli Memisoglu1, Frank B Hu, Susan E Hankinson, Simin Liu, James B Meigs, David M Altshuler, David J Hunter, JoAnn E Manson.   

Abstract

OBJECTIVE: To determine whether the Pro12Ala polymorphism in the PPARgamma gene was associated with risk of type 2 diabetes in the Nurses' Health Study. RESEARCH DESIGN AND METHODS: The study was a nested case-control study of 387 incident cases of type 2 diabetes and 771 matching control subjects nested within the Nurses' Health Study, a prospective cohort study. Association between PPARgamma genotype and incident type 2 diabetes was estimated using logistic regression.
RESULTS: Carriers of the PPARgamma variant 12Ala allele had reduced risk of type 2 diabetes compared with noncarriers. Unadjusted and adjusted odds ratios of type 2 diabetes were 0.74 (95% CI 0.55-1.00) and 0.72 (0.52-0.99), respectively.
CONCLUSIONS: The results of this study provide further support for an inverse association between the PPARgamma variant 12Ala allele and risk of type 2 diabetes.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14514601     DOI: 10.2337/diacare.26.10.2915

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  16 in total

Review 1.  [Genetics of type 2 diabetes].

Authors:  Y Böttcher; P Kovacs; A Tönjes; M Stumvoll
Journal:  Internist (Berl)       Date:  2005-07       Impact factor: 0.743

2.  The Genetic Basis of Type 2 Diabetes.

Authors:  Swapan Kumar Das; Steven C Elbein
Journal:  Cellscience       Date:  2006-04-30

3.  Common polymorphisms of the PPAR-gamma2 (Pro12Ala) and PGC-1alpha (Gly482Ser) genes are associated with the conversion from impaired glucose tolerance to type 2 diabetes in the STOP-NIDDM trial.

Authors:  L Andrulionytè; J Zacharova; J-L Chiasson; M Laakso
Journal:  Diabetologia       Date:  2004-12-08       Impact factor: 10.122

4.  Effects of the type 2 diabetes-associated PPARG P12A polymorphism on progression to diabetes and response to troglitazone.

Authors:  Jose C Florez; Kathleen A Jablonski; Maria W Sun; Nick Bayley; Steven E Kahn; Harry Shamoon; Richard F Hamman; William C Knowler; David M Nathan; David Altshuler
Journal:  J Clin Endocrinol Metab       Date:  2007-01-09       Impact factor: 5.958

5.  Relationships of dietary patterns with body composition in older adults differ by gender and PPAR-γ Pro12Ala genotype.

Authors:  Amy L Anderson; Tamara B Harris; Denise K Houston; Frances A Tylavsky; Jung Sun Lee; Deborah E Sellmeyer; Nadine R Sahyoun
Journal:  Eur J Nutr       Date:  2010-02-21       Impact factor: 5.614

6.  Genes, diet and type 2 diabetes mellitus: a review.

Authors:  George V Z Dedoussis; Andriana C Kaliora; Demosthenes B Panagiotakos
Journal:  Rev Diabet Stud       Date:  2007-05-10

Review 7.  PPAR gamma and human metabolic disease.

Authors:  Robert K Semple; V Krishna K Chatterjee; Stephen O'Rahilly
Journal:  J Clin Invest       Date:  2006-03       Impact factor: 14.808

8.  'Striking the Right Balance' in Targeting PPARgamma in the Metabolic Syndrome: Novel Insights from Human Genetic Studies.

Authors:  Mark Gurnell
Journal:  PPAR Res       Date:  2007       Impact factor: 4.964

9.  PPARγ2 polymorphism and human health.

Authors:  Weimin He
Journal:  PPAR Res       Date:  2009-04-16       Impact factor: 4.964

10.  Genetic prediction of future type 2 diabetes.

Authors:  Valeriya Lyssenko; Peter Almgren; Dragi Anevski; Marju Orho-Melander; Marketa Sjögren; Carola Saloranta; Tiinamaija Tuomi; Leif Groop
Journal:  PLoS Med       Date:  2005-11-01       Impact factor: 11.069

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.